Roberson Daniel, Jia Hanna, Vaughn David, Miller Christopher, Fogt Franz, Kovell R Caleb
Division of Urology, Department of Surgery, University of Pennsylvania Health System, Philadelphia, PA, USA.
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Urol Case Rep. 2022 Sep 20;45:102223. doi: 10.1016/j.eucr.2022.102223. eCollection 2022 Nov.
This 68-year-old male, with a history of treated testicular seminoma, developed scrotal SCC 30 years later, with a metastatic SCC recurrence following another interval of 10 years. He exhibited good response to multimodal therapy, though subsequently underwent orchiectomy, revealing SCC invading his solitary testicle. This case presents a unique danger of adjuvant radiation in testicular cancer survivors, demonstrates the efficacy of multimodal therapy with GU SCC, and describes a highly unusual histologic finding.
这位68岁男性有睾丸精原细胞瘤治疗史,30年后发生阴囊鳞状细胞癌(SCC),又过了10年出现转移性SCC复发。他对多模式治疗反应良好,不过随后接受了睾丸切除术,结果显示SCC侵犯了他唯一的睾丸。该病例呈现了睾丸癌幸存者辅助放疗的独特风险,证明了多模式治疗对泌尿生殖系统SCC的疗效,并描述了一种非常罕见的组织学发现。